subject: CHEBI:15640

object_name: Pancreatic carcinoma stage III


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stage III Pancreatic Cancer AJCC v6 and v7

tested_intervention: unsure


subject: CHEBI:15640

object_name: stage IIB pancreatic cancer


subject: CHEBI:15640

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:15640

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:15640

object_name: stage IIA pancreatic cancer


subject: CHEBI:15640

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:15640

object_name: Poorly Differentiated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Pancreas carcinoma resectable


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:151315

subject_name: Heparin

object_name: plasma cell myeloma


subject: CHEBI:151315

object_name: Pathologic fracture


subject: CHEBI:151315

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:151315

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:151315

object_name: sarcoma


subject: CHEBI:151315

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:151315

object_name: soft tissue sarcoma


subject: CHEBI:151315

object_name: metastatic neoplasm


subject: CHEBI:151315

object_name: Embolism, Tumor


subject: CHEBI:151315

object_name: Neoplasm Metastasis


subject: CHEBI:151315

object_name: Femur fracture


subject: CHEBI:151315

object_name: Osteosarcoma


subject: CHEBI:151315

object_name: bone sarcoma


subject: CHEBI:151315

object_name: adult lymphoma


subject: CHEBI:151315

object_name: lymphoma


subject: CHEBI:151315

object_name: pediatric lymphoma


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR

tested_intervention: yes


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:231679

object_name: head and neck squamous cell carcinoma


subject: CHEBI:231679

object_name: colorectal cancer


subject: CHEBI:231679

object_name: colorectal carcinoma


subject: CHEBI:231679

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:231679

object_name: urothelial carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Childhood Solid Neoplasm


subject: UNII:AF75XOF6W3

object_name: Adult Solid Neoplasm


subject: UNII:AF75XOF6W3

object_name: Solid Neoplasm


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: non-small cell lung carcinoma


subject: UNII:AF75XOF6W3

object_name: liver carcinoma


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: transitional cell carcinoma


subject: UNII:AF75XOF6W3

object_name: nonpapillary renal cell carcinoma


subject: UNII:AF75XOF6W3

object_name: clear cell renal carcinoma


subject: UNII:AF75XOF6W3

object_name: renal cell adenocarcinoma


subject: UNII:AF75XOF6W3

object_name: renal cell carcinoma


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: spondyloarthropathy


subject: UMLS:C1611967

object_name: pulmonary embolism


subject: GTOPDB:4934

subject_name: G-CSF

object_name: alcoholic hepatitis


subject: GTOPDB:4934

object_name: Acute-On-Chronic Liver Failure


subject: GTOPDB:4934

object_name: acute-on-chronic liver failure


subject: GTOPDB:4934

object_name: alcoholic liver cirrhosis


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:9919285


subject: PUBCHEM.COMPOUND:9919285


subject: PUBCHEM.COMPOUND:9919285


subject: PUBCHEM.COMPOUND:9919285


subject: UMLS:C2350950


subject: UMLS:C2350950


subject: UMLS:C2350950


subject: UMLS:C2350950


subject: PUBCHEM.COMPOUND:129887057

object_name: Alzheimer disease type 1


subject: UNII:K6396E6G8G


subject: UNII:7P55415B0R


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: alcohol dependence


subject: UNII:5Q6TZN2HNM

subject_name: Ecallantide

object_name: hereditary angioedema


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: Secondary oxalosis


subject: UNII:490D9F069T

object_name: nephrolithiasis


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:0M78EU4V9H


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C0719832

subject_name: Dextrose 2.5%

object_name: osteoarthritis, knee


subject: UMLS:C5570977

subject_name: 2.5% Dextrose


subject: CHEBI:478164

subject_name: Cefepime

object_name: leukemia


subject: CHEBI:478164

object_name: childhood leukemia


subject: CHEBI:478164

object_name: childhood malignant neoplasm


subject: CHEBI:478164

object_name: Adverse reaction to antibiotics


subject: CHEBI:478164

object_name: Febrile Neutropenia


subject: UMLS:C0016018

subject_name: Fibrinolytic Agents

object_name: pulmonary embolism


subject: CHEBI:31401

subject_name: Cilostazol

object_name: hyperlipidemia


subject: CHEBI:8427

subject_name: Probucol


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: leiomyosarcoma


subject: UNII:7SQY4ZUD30

object_name: Childhood Leiomyosarcoma


subject: UNII:7SQY4ZUD30

object_name: Adult Leiomyosarcoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: PUBCHEM.COMPOUND:23297360

subject_name: Nestorone

object_name: multiple endocrine neoplasia


subject: UMLS:C0283986


subject: CHEBI:135563

subject_name: elcometrine


subject: CHEBI:90881

subject_name: Camptosar

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:90881

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90881

object_name: Unresectable Solid Neoplasm


subject: CHEBI:90881

object_name: triple-negative breast carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: UNII:IF25NR1PV3

subject_name: TUNLAMETINIB

object_name: melanoma


subject: DRUGBANK:DB18791

subject_name: Tunlametinib


subject: CHEBI:41423

subject_name: Celecoxib

object_name: endogenous depression


subject: CHEBI:41423

object_name: major depressive disorder


subject: CHEBI:90998

subject_name: alvocidib hydrochloride

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:90998

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:90998

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:90998

object_name: Testis cancer recurrent


subject: CHEBI:90998

object_name: Recurrent Malignant Extragonadal Germ Cell Tumor


subject: CHEBI:90998

object_name: Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor


subject: CHEBI:90998

object_name: Recurrent Malignant Extragonadal Nongerminomatous Germ Cell Tumor


subject: CHEBI:90998

object_name: Recurrent Extragonadal Seminoma


subject: CHEBI:90998

object_name: stage III testicular cancer


subject: CHEBI:90998

object_name: Stage III Testicular Cancer AJCC v6 and v7


subject: CHEBI:90998

object_name: Stage III Testicular Cancer AJCC v8


subject: CHEBI:90998

object_name: Stage IV Extragonadal Seminoma


subject: UMLS:C2709282

subject_name: Alvocidib Hydrochloride


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:QEN1X95CIX

object_name: Carcinoma breast stage IV


subject: UNII:QEN1X95CIX

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: HER2/Neu Negative


subject: UNII:QEN1X95CIX

object_name: Breast cancer recurrent


subject: UNII:QEN1X95CIX

object_name: Estrogen Receptor Negative


subject: UNII:QEN1X95CIX

object_name: Estrogen Receptor Positive


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:154975891

object_name: High grade glioma


subject: PUBCHEM.COMPOUND:154975891

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:154975891

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:154975891

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:154975891

object_name: glioma susceptibility 1


subject: UMLS:C5706380

subject_name: EBP Inhibitor DSP-0390


subject: UMLS:C5706380


subject: UMLS:C5706380


subject: UMLS:C5706380


subject: UMLS:C5706380


subject: UNII:RB55ZW48XG


subject: UNII:RB55ZW48XG


subject: UNII:RB55ZW48XG


subject: UNII:RB55ZW48XG


subject: UNII:RB55ZW48XG


subject: PUBCHEM.COMPOUND:14907381

object_name: esophageal squamous cell carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345


subject: GTOPDB:8323

subject_name: monalizumab


subject: GTOPDB:8323


subject: GTOPDB:8323

object_name: esophageal adenocarcinoma


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Pregnant


subject: UNII:8O74K609HN

subject_name: Obicetrapib

object_name: elevated lipoprotein (a)


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: Childhood Breast Carcinoma


subject: UMLS:C5207052

object_name: breast carcinoma


subject: UMLS:C5207052

object_name: breast cancer


subject: UMLS:C5207052

object_name: HER2 positive breast carcinoma


subject: CHEBI:27504

subject_name: Mitomycin

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PUBCHEM.COMPOUND:6427057

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Sleep Deprivation


subject: CHEBI:3213

subject_name: Bumetanide

object_name: Heart Failure, CTCAE


subject: CHEBI:17287

subject_name: Phosphocreatine

object_name: heart failure


subject: CHEBI:17287

object_name: cardiac arrest


subject: CHEBI:17287

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:17287

object_name: respiratory failure


subject: CHEBI:17287

object_name: Respiratory Failure, CTCAE


subject: CHEBI:17287

object_name: Tachycardia by ECG Finding


subject: CHEBI:17287

object_name: Tachycardia


subject: CHEBI:17287

object_name: Bradycardia by ECG Finding


subject: CHEBI:17287

object_name: Bradycardia


subject: CHEBI:17287

object_name: hypotension


subject: CHEBI:17287

object_name: Hypotension, CTCAE


subject: CHEBI:17287

object_name: Altered Level of Consciousness


subject: CHEBI:17287

object_name: airway disease


subject: CHEBI:17287

object_name: Bradypnea


subject: CHEBI:17287

object_name: Tachypnea


subject: CHEBI:41879

object_name: Severe Dengue


subject: UMLS:C5452874

subject_name: Glulisine

object_name: diabetes mellitus


subject: UMLS:C0021641

subject_name: Insulin


subject: CHEBI:95341

subject_name: Baricitinib

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: UNII:2W150K0UUC

subject_name: Odevixibat

object_name: biliary atresia


subject: CHEBI:25413

subject_name: monounsaturated fatty acid

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:25413

object_name: obesity


subject: CHEBI:25413

object_name: Obesity, CTCAE


subject: CHEBI:76567

subject_name: polyunsaturated fatty acid anion


subject: CHEBI:76567


subject: CHEBI:76567


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids


subject: UMLS:C0032615


subject: UMLS:C0032615


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:26208


subject: CHEBI:26208


subject: CHEBI:26607

subject_name: saturated fatty acid


subject: CHEBI:26607


subject: CHEBI:26607


subject: UniProtKB:P0AAA5

subject_name: YMCE_ECOLI Uncharacterized protein YmcE (sprot)


subject: UniProtKB:P0AAA5


subject: UniProtKB:P0AAA5


subject: PR:000034221

subject_name: uncharacterized protein YmcE


subject: PR:000034221


subject: PR:000034221


subject: CHEBI:167308

subject_name: Dextromethadone

object_name: neuralgia


subject: CHEBI:167308

object_name: Neuropathic pain


subject: UMLS:C5708868

subject_name: Cretostimogene Grenadenorepvec

object_name: bladder tumor


subject: UMLS:C5708868

object_name: urinary bladder carcinoma


subject: UMLS:C5708868

object_name: urinary bladder cancer


subject: UMLS:C5708868

object_name: childhood bladder carcinoma


subject: UMLS:C5708868

object_name: malignant urinary system neoplasm


subject: UMLS:C5708868

object_name: urothelial carcinoma


subject: UMLS:C5708868

object_name: transitional cell carcinoma


subject: CHEBI:233309

subject_name: Adagrasib

object_name: Primary malignant neoplasm


subject: CHEBI:233309

object_name: childhood malignant neoplasm


subject: CHEBI:233309

object_name: Malignant obstetric neoplasm


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849

object_name: Advanced cancer


subject: UMLS:C4763658

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4763658

object_name: Embolism, Tumor


subject: UMLS:C4763658

object_name: Neoplasm Metastasis


subject: UMLS:C4763658


subject: UMLS:C4763658

object_name: cancer


subject: UMLS:C4763658


subject: UMLS:C4763658


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Adult Solid Neoplasm


subject: UMLS:C2699335


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: trigeminal neuralgia


subject: CHEBI:3160

object_name: headache disorder


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Childhood Breast Carcinoma


subject: CHEBI:60802

object_name: breast carcinoma


subject: CHEBI:60802

object_name: breast cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:64816


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:143658


subject: CHEBI:52172

subject_name: Nilotinib

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:52172

object_name: acute lymphoblastic leukemia


subject: CHEBI:52172

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:52172

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Infection


subject: CHEBI:51254

object_name: infectious disease


subject: CHEBI:51254

object_name: Adverse Event Associated with Infection


subject: CHEBI:51254

object_name: abdominal abscess


subject: CHEBI:51254

object_name: Abdominal pain


subject: CHEBI:51254

object_name: Abdominal Pain, CTCAE


subject: CHEBI:51254

object_name: intestinal perforation


subject: CHEBI:51254

object_name: Acute abdomen


subject: CHEBI:51254

object_name: appendicitis


subject: CHEBI:51254

object_name: Appendicitis, CTCAE


subject: CHEBI:51254

object_name: peritonitis


subject: CHEBI:51254

object_name: Laceration


subject: CHEBI:51254

object_name: ileus


subject: CHEBI:51254

object_name: Ileus, CTCAE


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:135928

subject_name: Doripenem


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:6770

subject_name: MEROPENEM


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: UNII:PP0SHH6V16

subject_name: Alirocumab


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: xerophthalmia


subject: CHEBI:16347

object_name: dry eye syndrome


subject: CHEBI:16347

object_name: Sicca Syndrome


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: acute kidney failure


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C5418142

subject_name: Pyramax


subject: CHEBI:30015

subject_name: L-valine residue

object_name: hypertension


subject: CHEBI:30015

object_name: arthritis


subject: CHEBI:30015

object_name: Arthritis, CTCAE


subject: CHEBI:30015

object_name: type 2 diabetes mellitus


subject: CHEBI:30015

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:30015

object_name: obesity


subject: CHEBI:30015

object_name: Obesity, CTCAE


subject: CHEBI:16414

subject_name: Valine


subject: CHEBI:16414


subject: CHEBI:16414


subject: CHEBI:16414


subject: CHEBI:16414


subject: CHEBI:16414


subject: CHEBI:16414


subject: UniProtKB:Q98UK5

subject_name: MAFB_DANRE Transcription factor MafB (sprot)


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:60125


subject: CHEBI:8707

subject_name: Quetiapine

object_name: social phobia


subject: CHEBI:15354

subject_name: Choline

object_name: Prostate cancer recurrent


subject: CHEBI:15354

object_name: prostate carcinoma


subject: CHEBI:15354

object_name: prostate cancer


subject: UMLS:C2703133

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C2703133

object_name: Indolent lymphoma


subject: UMLS:C2703133

object_name: Hodgkin Disease


subject: UMLS:C2703133

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C2703133

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C2703133

object_name: mantle cell lymphoma


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350


subject: CHEBI:231350


subject: CHEBI:231350


subject: CHEBI:231350


subject: CHEBI:231350


subject: UMLS:C4745027

subject_name: SERD D-0502

object_name: Childhood Breast Carcinoma


subject: UMLS:C4745027

object_name: breast carcinoma


subject: UMLS:C4745027

object_name: breast cancer


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Bladder cancer recurrent


subject: PUBCHEM.COMPOUND:58827053

subject_name: Osilodrostat

object_name: Hepatic impairment


subject: PR:000005280

subject_name: cyclin-dependent kinase inhibitor 3

object_name: Depressed mood


subject: PR:000005280

object_name: Cancer patients and suicide and depression


subject: PR:000005280

object_name: Depressed - symptom


subject: PR:000005280

object_name: Depression, CTCAE


subject: PR:000005280

object_name: anxiety


subject: PR:000005280

object_name: anxiety disorder


subject: PR:000005280

object_name: Anxiety symptoms


subject: PR:000005280

object_name: Anxiety, CTCAE 3.0


subject: PR:000005280

object_name: Anxiety, CTCAE 5.0


subject: PR:000005280

object_name: post-traumatic stress disorder


subject: PR:000010986

subject_name: napsin-A


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000010986


subject: PR:000009240

subject_name: kidney androgen-regulated protein


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: PR:000009240


subject: UMLS:C5667044

subject_name: Botanical-based Agent NBT-NM108

object_name: Prader-Willi syndrome


subject: UMLS:C5667044

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5667044

object_name: obesity


subject: UMLS:C5667044

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:74412639

subject_name: Solithromycin

object_name: gonorrhea


subject: UMLS:C5666993

subject_name: ROS1 Inhibitor NUV-520

object_name: non-small cell lung carcinoma


subject: CHEBI:37845

subject_name: growth hormone

object_name: hypothyroidism


subject: CHEBI:37845

object_name: Hypothyroidism, CTCAE


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Erdheim-Chester disease


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Addictive benzodiazepine use


subject: CHEBI:42797

object_name: opiate dependence


subject: UMLS:C0767948

object_name: myelofibrosis


subject: UMLS:C0767948

object_name: leukemia


subject: UMLS:C0767948

object_name: childhood leukemia


subject: CHEBI:83766

subject_name: Olaparib

object_name: primary peritoneal carcinoma


subject: CHEBI:83766

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:83766

object_name: peritoneal carcinoma


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Chronic uremia


subject: UMLS:C5854530

subject_name: Heat Shock Factor 1 Pathway Inhibitor NXP800

object_name: ovarian cancer


subject: UMLS:C5854530

object_name: ovarian neoplasm


subject: UMLS:C5854530

object_name: ovarian carcinoma


subject: UMLS:C5854530

object_name: ovarian endometrial cancer


subject: UMLS:C5854530

object_name: ovarian clear cell tumor


subject: UMLS:C5854530

object_name: Ovarian clear cell carcinoma


subject: UMLS:C5854530

object_name: ovarian clear cell cancer


subject: UMLS:C5854530

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C5854530

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C5854530

object_name: ARID1A gene mutation


subject: UMLS:C5854530

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5446615

subject_name: ALK2 Inhibitor INCB000928

object_name: fibrodysplasia ossificans progressiva


subject: CHEBI:84500

subject_name: varenicline

object_name: coronary artery disorder


subject: CHEBI:84500

object_name: coronary atherosclerosis


subject: UMLS:C1699394

subject_name: Hylenex

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: carcinoid tumor


subject: CHEBI:72313

subject_name: pasireotide aspartate


subject: UMLS:C1136845


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: lung cancer


subject: UNII:DPT0O3T46P

object_name: lung neoplasm


subject: UNII:DPT0O3T46P

object_name: lung carcinoma


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: neoplasm


subject: UMLS:C5238233

object_name: pancreatic neoplasm


subject: UMLS:C5238233

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5238233

object_name: malignant pancreatic neoplasm


subject: UMLS:C5238233

object_name: ovarian cancer


subject: UMLS:C5238233

object_name: ovarian neoplasm


subject: UMLS:C5238233

object_name: Childhood Breast Carcinoma


subject: UMLS:C5238233

object_name: breast carcinoma


subject: UMLS:C5238233

object_name: breast cancer


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: UMLS:C0717892

subject_name: loperamide / simethicone

object_name: diarrhea


subject: UMLS:C0717892

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C0717892

object_name: Diarrhea, CTCAE


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: clonic hemifacial spasm


subject: CHEBI:3160

object_name: Hemifacial spasm


subject: CHEBI:50853

subject_name: quantum dot

object_name: Atopic rhinitis


subject: CHEBI:50853

object_name: Hay fever


subject: CHEBI:174615

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:174615

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:174615

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:32188

subject_name: Tegafur

object_name: colorectal cancer


subject: CHEBI:32188

object_name: colorectal carcinoma


subject: CHEBI:32188

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:17568

subject_name: Uracil


subject: CHEBI:17568


subject: CHEBI:17568


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Bell's palsy


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:G1G66XE93W

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Osteosarcoma


subject: CHEBI:4026

object_name: Refractory Neuroblastoma


subject: CHEBI:4026

object_name: Refractory Childhood Neuroblastoma


subject: CHEBI:4026

object_name: Refractory Childhood Osteosarcoma


subject: CHEBI:4026

object_name: Osteosarcoma recurrent


subject: CHEBI:4026

object_name: Recurrent Childhood Neuroblastoma


subject: CHEBI:4026

object_name: Recurrent Childhood Osteosarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Neuroblastoma recurrent


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: dyspepsia


subject: CHEBI:2666

object_name: Dyspepsia, CTCAE


subject: CHEBI:47781

subject_name: Desipramine


subject: CHEBI:47781


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Upper Extremity Deep Vein Thrombosis, Secondary


subject: CHEBI:68579

object_name: Upper Extremity Deep Vein Thrombosis


subject: UNII:DL772G3NN7

object_name: Stomach cancer


subject: UNII:DL772G3NN7

object_name: gastric cancer


subject: UNII:DL772G3NN7

object_name: Gastroesophageal junction cancer


subject: UMLS:C4329327

subject_name: Anti-Glypican 3/CD3 Bispecific Antibody ERY974

object_name: liver carcinoma


subject: CHEBI:149509

object_name: type 2 diabetes mellitus


subject: CHEBI:3347

subject_name: Candesartan


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: glioma susceptibility 1


subject: UNII:16VY3TM7ZO

object_name: ependymoma


subject: UNII:16VY3TM7ZO

object_name: childhood ependymoma


subject: UNII:16VY3TM7ZO

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:16VY3TM7ZO

object_name: Adult Ependymoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: cholangiocarcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: pancreatic neoplasm


subject: UMLS:C5669600

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5669600

object_name: malignant pancreatic neoplasm


subject: UNII:VKU5X213Q7

object_name: Childhood Breast Carcinoma


subject: UNII:VKU5X213Q7

object_name: breast carcinoma


subject: UNII:VKU5X213Q7

object_name: breast cancer


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Heart failure with normal ejection fraction


subject: CHEBI:15372


subject: CHEBI:15372

object_name: Inflammation


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E


subject: PUBCHEM.COMPOUND:5320784


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:16349

subject_name: Citrulline


subject: CHEBI:16349


subject: CHEBI:91951

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: lymphoid leukemia


subject: PUBCHEM.COMPOUND:86305217

subject_name: DALZANEMDOR

object_name: Mild dementia


subject: PUBCHEM.COMPOUND:86305217

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:86305217

object_name: Alzheimer disease


subject: CHEBI:6931

subject_name: Midazolam

object_name: Postoperative cognitive dysfunction


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UNII:3B974D670O

object_name: impotence


subject: UNII:3B974D670O

object_name: Erectile Dysfunction, CTCAE


subject: UNII:3B974D670O

object_name: Erectile dysfunction


subject: UNII:I7MVZ8HDNU

subject_name: Remibrutinib

object_name: chronic idiopathic urticaria


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Breastfeeding (mother)


subject: UMLS:C0699913

subject_name: Maxolon


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Gastrointestinal hemorrhage


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: cocaine abuse


subject: CHEBI:5118

object_name: opiate dependence


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: colorectal cancer


subject: CHEBI:63584

object_name: colorectal carcinoma


subject: CHEBI:63584

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4287748

subject_name: Anti-CD123/CD3 Bispecific Antibody JNJ-63709178

object_name: acute myeloid leukemia


subject: UNII:789Q85GA8P

subject_name: Vorasidenib

object_name: Epithelioma


subject: UNII:789Q85GA8P

object_name: germ cell tumor


subject: UNII:789Q85GA8P

object_name: Neoplasms by Histologic Type


subject: UNII:789Q85GA8P

object_name: Pathologic Processes


subject: UNII:789Q85GA8P

object_name: neuroepithelial neoplasm


subject: UNII:789Q85GA8P

object_name: nervous system cancer


subject: UNII:789Q85GA8P

object_name: primitive neuroectodermal tumor


subject: UNII:789Q85GA8P

object_name: peripheral primitive neuroectodermal tumor


subject: UNII:789Q85GA8P

object_name: Disease Attributes


subject: UNII:789Q85GA8P

object_name: Recurrence


subject: UNII:789Q85GA8P

object_name: Recurrent Malignant Neoplasm


subject: UNII:789Q85GA8P

object_name: Recurrent disease


subject: UNII:789Q85GA8P

object_name: Recurrent tumor


subject: UNII:789Q85GA8P

object_name: neoplasm


subject: CHEBI:6432

subject_name: Levamisole

object_name: focal epilepsy


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Recurrent Childhood Gliosarcoma


subject: CHEBI:41879

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:41879

object_name: Recurrent Childhood Gliomatosis Cerebri


subject: CHEBI:41879

object_name: Recurrent Childhood Giant Cell Glioblastoma


subject: CHEBI:41879

object_name: Recurrent Childhood Anaplastic Oligodendroglioma


subject: CHEBI:41879

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: CHEBI:41879

object_name: Recurrent Childhood Anaplastic Oligoastrocytoma


subject: UMLS:C2827518

subject_name: Oncolytic HSV1716


subject: UMLS:C2827518


subject: UMLS:C2827518


subject: UMLS:C2827518


subject: UMLS:C2827518


subject: UMLS:C2827518


subject: UMLS:C2827518


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pediatric osteosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Osteosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: undifferentiated high grade pleomorphic sarcoma of bone


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:32682

subject_name: L-argininium

object_name: glucose intolerance


subject: CHEBI:32682

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: PR:000022673

subject_name: antigen 43

object_name: asthma


subject: CHEBI:30762

subject_name: salicylate


subject: CHEBI:24866

subject_name: salt


subject: PR:000014438

subject_name: Sal-like protein 3


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Disorder related to renal transplantation


subject: UNII:DW2NWI3TFN

object_name: melanoma


subject: UNII:3I0ORO8174

subject_name: MEM

object_name: childhood acute lymphoblastic leukemia


subject: UNII:3I0ORO8174

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:3I0ORO8174

object_name: Acute lymphoblastic leukemia, in relapse


subject: UNII:3I0ORO8174

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:8382

subject_name: Prednisone

object_name: Esophageal stricture


subject: CHEBI:8382

object_name: Esophageal stenosis


subject: CHEBI:8382

object_name: Esophageal Stenosis, CTCAE


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: small cell lung carcinoma


subject: UMLS:C0879250

subject_name: HER-2-neu peptide vaccine

object_name: Breast cancer stage II


subject: UMLS:C0879250

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C0879250

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0879250

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0879250

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0879250

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0879250

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Disease Progression


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5201230

object_name: Embolism, Tumor


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: UMLS:C3854151


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: Neck Carcinoma


subject: UNII:QMS40680K6

object_name: head and neck neoplasm


subject: UNII:QMS40680K6

object_name: head and neck cancer


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: type 2 diabetes mellitus


subject: UNII:2252724U5N

object_name: glioma


subject: UNII:2252724U5N

object_name: malignant glioma


subject: UMLS:C3896847

subject_name: hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1

object_name: acute myeloid leukemia


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: actinic keratosis


subject: UMLS:C1512511

object_name: squamous cell carcinoma


subject: UMLS:C1512511

object_name: basal cell carcinoma


subject: UMLS:C1512511

object_name: skin basal cell carcinoma


subject: UMLS:C0282575

subject_name: Micronutrients

object_name: Pediatric Obesity


subject: UMLS:C2744646

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C2744646

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C2744646

object_name: neuroendocrine neoplasm


subject: UMLS:C2744646

object_name: APUdoma


subject: UMLS:C2744646

object_name: carcinoid tumor


subject: UMLS:C2744646

object_name: digestive system neuroendocrine neoplasm


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: central diabetes insipidus


subject: UMLS:C1250042

object_name: neurohypophyseal diabetes insipidus


subject: UMLS:C1250042

object_name: Oxytocin deficiency


subject: CHEBI:31596

subject_name: Febuxostat

object_name: hypertension


subject: CHEBI:31596

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:162462321

subject_name: Icotrokinra

object_name: ulcerative colitis


subject: UMLS:C5960070


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: acute graft versus host disease


subject: UMLS:C0665297

subject_name: natalizumab


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:135530

subject_name: Solifenacin

object_name: urinary tract infection


subject: CHEBI:135530

object_name: bacterial urinary tract infection


subject: CHEBI:135530

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:16796

subject_name: Melatonin

object_name: Dengue fever with warning signs


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Childhood Brain Neoplasm


subject: UNII:DPT0O3T46P

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:DPT0O3T46P

object_name: B-cell neoplasm


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: refractory hairy cell leukemia


subject: CHEBI:50223

object_name: small intestine lymphoma


subject: CHEBI:50223

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:50223

object_name: acute undifferentiated leukemia


subject: CHEBI:50223

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:50223

object_name: intraocular lymphoma


subject: CHEBI:50223

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:50223

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:50223

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:50223

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:50223

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:50223

object_name: Burkitt lymphoma


subject: CHEBI:50223

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:50223

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:50223

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:50223

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:50223

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:50223

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:50223

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:50223

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50223

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:50223

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:50223

object_name: Blast Phase


subject: CHEBI:50223

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:50223

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:50223

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:50223

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:50223

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50223

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:50223

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:50223

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:50223

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:50223

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:91872

object_name: refractory hairy cell leukemia


subject: CHEBI:91872

object_name: small intestine lymphoma


subject: CHEBI:91872

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:91872

object_name: acute undifferentiated leukemia


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:91872

object_name: intraocular lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:91872

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91872

object_name: Blast Phase


subject: CHEBI:91872

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:91872

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:91872

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:91872

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:91872

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91872

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:91872

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:91872

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:91872

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: refractory hairy cell leukemia


subject: CHEBI:28748

object_name: small intestine lymphoma


subject: CHEBI:28748

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:28748

object_name: acute undifferentiated leukemia


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:28748

object_name: intraocular lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:28748

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28748

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28748

object_name: Blast Phase


subject: CHEBI:28748

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:28748

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:28748

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:28748

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:28748

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28748

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:28748

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28748

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:28748

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:28445

subject_name: vincristine

object_name: refractory hairy cell leukemia


subject: CHEBI:28445

object_name: small intestine lymphoma


subject: CHEBI:28445

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:28445

object_name: acute undifferentiated leukemia


subject: CHEBI:28445

object_name: intraocular lymphoma


subject: CHEBI:28445

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:28445

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:28445

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:28445

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28445

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28445

object_name: Blast Phase


subject: CHEBI:28445

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:28445

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:28445

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:28445

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:28445

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28445

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:28445

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:28445

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28445

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:28445

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Infant Acute Undifferentiated Leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: acute undifferentiated leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:16681698

object_name: intraocular lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Childhood Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: unspecified childhood solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:16681698

object_name: Childhood Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:16681698

object_name: recurrent childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: primary cutaneous B-cell lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:16681698

object_name: noncutaneous extranodal lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:16681698

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:94522

object_name: refractory hairy cell leukemia


subject: CHEBI:94522

object_name: small intestine lymphoma


subject: CHEBI:94522

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:94522

object_name: acute undifferentiated leukemia


subject: CHEBI:94522

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:94522

object_name: intraocular lymphoma


subject: CHEBI:94522

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:94522

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:94522

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:94522

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:94522

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:94522

object_name: Burkitt lymphoma


subject: CHEBI:94522

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:94522

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:94522

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:94522

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:94522

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:94522

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:94522

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:94522

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:94522

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:94522

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:94522

object_name: Blast Phase


subject: CHEBI:94522

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:94522

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:94522

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:94522

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:94522

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:94522

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:94522

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:94522

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:94522

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:94522

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate

object_name: refractory hairy cell leukemia


subject: UNII:39200FJ43J

object_name: small intestine lymphoma


subject: UNII:39200FJ43J

object_name: Infant Acute Undifferentiated Leukemia


subject: UNII:39200FJ43J

object_name: acute undifferentiated leukemia


subject: UNII:39200FJ43J

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:39200FJ43J

object_name: intraocular lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:39200FJ43J

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UNII:39200FJ43J

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:39200FJ43J

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UNII:39200FJ43J

object_name: Burkitt lymphoma


subject: UNII:39200FJ43J

object_name: Childhood Burkitt Lymphoma


subject: UNII:39200FJ43J

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:39200FJ43J

object_name: Childhood Immunoblastic Lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UNII:39200FJ43J

object_name: hepatosplenic T-cell lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UNII:39200FJ43J

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:39200FJ43J

object_name: Blast Phase


subject: UNII:39200FJ43J

object_name: recurrent childhood acute myeloid leukemia


subject: UNII:39200FJ43J

object_name: primary cutaneous B-cell lymphoma


subject: UNII:39200FJ43J

object_name: acute leukemia of ambiguous lineage


subject: UNII:39200FJ43J

object_name: noncutaneous extranodal lymphoma


subject: UNII:39200FJ43J

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:39200FJ43J

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:39200FJ43J

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:39200FJ43J

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: UNII:39200FJ43J

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UNII:39200FJ43J

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C1831948

subject_name: obatoclax mesylate

object_name: refractory hairy cell leukemia


subject: UMLS:C1831948

object_name: small intestine lymphoma


subject: UMLS:C1831948

object_name: Infant Acute Undifferentiated Leukemia


subject: UMLS:C1831948

object_name: acute undifferentiated leukemia


subject: UMLS:C1831948

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C1831948

object_name: intraocular lymphoma


subject: UMLS:C1831948

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C1831948

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C1831948

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C1831948

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C1831948

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UMLS:C1831948

object_name: Burkitt lymphoma


subject: UMLS:C1831948

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C1831948

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C1831948

object_name: Childhood Immunoblastic Lymphoma


subject: UMLS:C1831948

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UMLS:C1831948

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C1831948

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C1831948

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C1831948

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1831948

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UMLS:C1831948

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C1831948

object_name: Blast Phase


subject: UMLS:C1831948

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C1831948

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C1831948

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C1831948

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C1831948

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1831948

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1831948

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C1831948

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1831948

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C1831948

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN

object_name: Parkinson disease


subject: UMLS:C0086135

subject_name: DDAVP


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: systolic heart failure


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: gastroesophageal cancer


subject: PUBCHEM.COMPOUND:44208928

subject_name: Chirhostim

object_name: pancreas disorder


subject: CHEBI:232390


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: Epileptic encephalopathy


subject: CHEBI:59729

object_name: Lennox-Gastaut syndrome


subject: CHEBI:5000

subject_name: Fenfluramine


subject: CHEBI:5000


subject: UNII:X7F1935FL1

object_name: Alzheimer disease


subject: DRUGBANK:DB19223


subject: UMLS:C0002932

subject_name: Anesthetics

object_name: pharyngitis


subject: UMLS:C0002932

object_name: Pharyngitis, CTCAE


subject: UMLS:C0002932

object_name: acute pharyngitis


subject: UMLS:C0002932

object_name: nasopharyngitis


subject: UMLS:C5399725

subject_name: Anesthetic [APC]


subject: UMLS:C5399725


subject: UMLS:C5399725


subject: UMLS:C5399725


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Childhood Synovial Sarcoma


subject: CHEBI:4026

object_name: Adult Synovial Sarcoma


subject: CHEBI:4026

object_name: synovial sarcoma


subject: CHEBI:4026

object_name: myxoid liposarcoma


subject: CHEBI:4026

object_name: myxoid/round cell liposarcoma


subject: CHEBI:4026

object_name: skin melanoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:B2I7YTE4ZA

subject_name: DUVAKITUG

object_name: ulcerative colitis


subject: UNII:B2I7YTE4ZA

object_name: inflammatory bowel disease 1


subject: UMLS:C5855311

subject_name: Duvakitug


subject: UMLS:C5855311


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:114785

object_name: skin squamous cell carcinoma


subject: CHEBI:114785

object_name: Recurrent Skin Carcinoma


subject: UMLS:C4053638

subject_name: MAGE-A3-specific Immunotherapeutic GSK 2132231A

object_name: melanoma


subject: CHEBI:31627

subject_name: FP 83

object_name: Surgical procedure finding


subject: CHEBI:31627

object_name: chronic rhinosinusitis


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:9316


subject: PUBCHEM.COMPOUND:86821

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:86821

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:86821

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:86821

object_name: Serum lipids high (finding)


subject: CHEBI:28824

subject_name: stigmasterol


subject: CHEBI:28824


subject: CHEBI:28824


subject: CHEBI:28824


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:27693

subject_name: beta-Sitosterol


subject: CHEBI:27693


subject: CHEBI:27693


subject: CHEBI:27693


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: sensory peripheral neuropathy


subject: CHEBI:73024

object_name: Peripheral Sensory Neuropathy, CTCAE


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: MESH:C568346

subject_name: ClinOleic

object_name: Prematurity of fetus


subject: MESH:C568346

object_name: Premature infant


subject: CHEBI:166975

subject_name: soybean oil


subject: CHEBI:166975


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: MESH:C008288

subject_name: Lipofundin


subject: MESH:C008288


subject: UMLS:C4548561

object_name: pyruvate kinase deficiency of red cells


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: hormone deficiency


subject: UNII:4UR7N9Z9MM

subject_name: Somatorelin


subject: GTOPDB:3602

subject_name: GHRH


subject: UNII:N0YWS8X3S9

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4085974


subject: CHEBI:15361

subject_name: pyruvate

object_name: OPTN-related open angle glaucoma


subject: CHEBI:15361

object_name: open-angle glaucoma


subject: MESH:D011773

subject_name: Pyruvates


subject: MESH:D011773


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:32816


subject: CHEBI:95341

subject_name: Baricitinib

object_name: chronic graft versus host disease


subject: UMLS:C1098055

subject_name: follicle stimulating hormone, human, with HCG C-terminal peptide

object_name: infertility


subject: CHEBI:4453

subject_name: Desogestrel


subject: CHEBI:61080

subject_name: Romidepsin

object_name: prostate carcinoma


subject: CHEBI:61080

object_name: prostate cancer


subject: CHEBI:61080

object_name: Embolism, Tumor


subject: CHEBI:61080

object_name: Neoplasm Metastasis


subject: CHEBI:61080

object_name: Metastatic Lesion


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: psychosis


subject: CHEBI:5118

object_name: personality disorder


subject: UMLS:C5206815

object_name: liver carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hyperglycemia


subject: CHEBI:73604

object_name: Hyperglycemia, CTCAE


subject: CHEBI:73604

object_name: Glucose in blood specimen above reference range


subject: CHEBI:73604

object_name: hypoglycemia


subject: CHEBI:73604

object_name: Blood glucose below reference range (finding)


subject: CHEBI:73604

object_name: Hypoglycemia, CTCAE


subject: UMLS:C4329699

subject_name: DPX-E7 HPV Vaccine

object_name: head and neck cancer


subject: UMLS:C4329699

object_name: cervical cancer


subject: UMLS:C4329699

object_name: cervical carcinoma


subject: UMLS:C4329699

object_name: anus cancer


subject: UMLS:C4329699

object_name: anal carcinoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Advanced cancer


subject: UNII:PQX0D8J21J

object_name: liver cancer


subject: UNII:PQX0D8J21J

object_name: liver neoplasm


subject: UNII:PQX0D8J21J

object_name: Adult Liver Carcinoma


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:0J4C69C6FB

subject_name: monteplase

object_name: pulmonary embolism


subject: UMLS:C1172255


subject: CHEBI:34945

object_name: type 1 diabetes mellitus 1


subject: CHEBI:34945

object_name: type 1 diabetes mellitus


subject: CHEBI:34945

object_name: type 2 diabetes mellitus


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UNII:7662KG2R6K


subject: UNII:7662KG2R6K


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: Cellulite


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Carcinoma breast stage IV


subject: UNII:8F5X4B082E

subject_name: Lixivaptan

object_name: polycystic kidney disease 1


subject: UNII:8F5X4B082E

object_name: autosomal dominant polycystic kidney disease


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: acute respiratory distress syndrome


subject: PR:000005931


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: aortic dissection


subject: UMLS:C3540778

object_name: Aortic dissection


subject: CHEBI:24261

subject_name: glucocorticoid


subject: CHEBI:24261


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UMLS:C3540777


subject: UMLS:C0879272

object_name: non-small cell lung carcinoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:50692

subject_name: Mifepristone

object_name: post-traumatic stress disorder


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: stage IV pancreatic cancer


subject: CHEBI:38940

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:38940

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:38940

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:38940

object_name: Pancreatic carcinoma stage III


subject: CHEBI:38940

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: pancreatic adenocarcinoma


subject: CHEBI:38940

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: esophageal squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:PQX0D8J21J

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:PQX0D8J21J

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:PQX0D8J21J

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: Hypovolemia


subject: UMLS:C0350411

object_name: Hyperoxia


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Severe acute respiratory syndrome of upper respiratory tract


subject: UMLS:C0013227

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: UMLS:C0013227

object_name: Severe acute respiratory infection


subject: UMLS:C0013227

object_name: severe acute respiratory syndrome


subject: UMLS:C0013227

object_name: neuroinflammatory response


subject: UMLS:C0013227

object_name: neurodegenerative disease


subject: UMLS:C0013227

object_name: Coronavinae infectious disease


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Childhood Breast Carcinoma


subject: UNII:2Y3T5IF01Z

object_name: breast carcinoma


subject: UNII:2Y3T5IF01Z

object_name: breast cancer


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: GTOPDB:8407

subject_name: etrolizumab

object_name: ulcerative colitis


subject: CHEMBL.COMPOUND:CHEMBL1743015

subject_name: ETROLIZUMAB


subject: UNII:4HTE364XIK

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:4HTE364XIK

object_name: liver carcinoma


subject: UNII:4HTE364XIK

object_name: liver cancer


subject: UNII:4HTE364XIK

object_name: liver neoplasm


subject: UNII:4HTE364XIK

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:71717200

subject_name: Istaroxime

object_name: heart failure


subject: PUBCHEM.COMPOUND:71717200

object_name: Heart Failure, CTCAE


subject: UMLS:C2932252

object_name: Primary Insomnia


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:90943

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:90943

object_name: Stage IVA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3367

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:24993045

object_name: type 1 diabetes mellitus


subject: CHEBI:95021

subject_name: pemetrexed

object_name: carcinoma of urethra


subject: CHEBI:95021

object_name: urethra cancer


subject: CHEBI:95021

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:95021

object_name: bladder tumor


subject: CHEBI:95021

object_name: urinary bladder carcinoma


subject: CHEBI:95021

object_name: urinary bladder cancer


subject: CHEBI:95021

object_name: childhood bladder carcinoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Laryngeal edema


subject: CHEBI:6888

object_name: Laryngeal Edema, CTCAE


subject: CHEBI:6888

object_name: Dysphagia


subject: CHEBI:6888

object_name: Dysphagia, CTCAE


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:KXG2PJ551I

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:KXG2PJ551I

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:KXG2PJ551I

object_name: anaplastic large cell lymphoma


subject: UNII:KXG2PJ551I

object_name: mycosis fungoides


subject: UNII:KXG2PJ551I

object_name: Sezary syndrome


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: DRUGBANK:DB17545

subject_name: Jaktinib

object_name: alopecia areata


subject: DRUGBANK:DB17545

object_name: alopecia


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:232556

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:232556

object_name: Refractory Rhabdoid Tumor


subject: CHEBI:232556

object_name: Refractory Ependymoma


subject: CHEBI:232556

object_name: Refractory Neuroblastoma


subject: CHEBI:232556

object_name: Refractory Hepatoblastoma


subject: CHEBI:232556

object_name: Refractory Langerhans Cell Histiocytosis


subject: CHEBI:232556

object_name: Refractory Medulloblastoma


subject: CHEBI:232556

object_name: Refractory Malignant Glioma


subject: CHEBI:232556

object_name: Refractory Childhood Osteosarcoma


subject: CHEBI:232556

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:232556

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: CHEBI:232556

object_name: Refractory Childhood Rhabdomyosarcoma


subject: CHEBI:232556

object_name: nephroblastoma


subject: CHEBI:232556

object_name: Wilms tumor


subject: CHEBI:232556

object_name: childhood kidney Wilms tumor


subject: CHEBI:232556

object_name: Refractory Childhood Soft Tissue Sarcoma


subject: CHEBI:232556

object_name: Recurrent Langerhans Cell Histiocytosis


subject: CHEBI:232556

object_name: Recurrent Rhabdoid Tumor


subject: CHEBI:232556

object_name: Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:232556

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:232556

object_name: Recurrent tumors of the Ewing's family


subject: CHEBI:232556

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:232556

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:232556

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:232556

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:232556

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:232556

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:232556

object_name: Recurrent Childhood Osteosarcoma


subject: CHEBI:232556

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:232556

object_name: Recurrent Malignant Glioma


subject: CHEBI:232556

object_name: Hepatoblastoma recurrent


subject: CHEBI:232556

object_name: Neuroblastoma recurrent


subject: UNII:I02418V13W

subject_name: Ziritaxestat

object_name: interstitial lung disease 1


subject: UNII:I02418V13W

object_name: interstitial lung disease 2


subject: CHEBI:233197

subject_name: devimistat

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:233197

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:233197

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:233197

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:233197

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:233197

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:233197

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:44915

subject_name: Propofol

object_name: Emergencies


subject: CHEBI:62247

object_name: urinary tract infection


subject: CHEBI:62247

object_name: bacterial urinary tract infection


subject: CHEBI:62247

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: PUBCHEM.COMPOUND:44151255

subject_name: Dirucotide

object_name: secondary progressive multiple sclerosis


subject: UNII:26188K0CWH


subject: UMLS:C4282231


subject: CHEBI:39462

subject_name: pilocarpine

object_name: Xerostomia


subject: CHEBI:39462

object_name: Dry Mouth, CTCAE


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:8207


subject: UMLS:C5961160

subject_name: Anti-TAAs/Anti-CD3/Anti-CD28 Tetra-specific Antibody MDX2001

object_name: endometrial cancer


subject: UMLS:C5961160

object_name: uterine corpus cancer


subject: UMLS:C5961160

object_name: endometrial carcinoma


subject: UMLS:C5961160

object_name: Neck Carcinoma


subject: UMLS:C5961160

object_name: head and neck neoplasm


subject: UMLS:C5961160

object_name: head and neck cancer


subject: UMLS:C5961160

object_name: cervical cancer


subject: UMLS:C5961160

object_name: cervical carcinoma


subject: UMLS:C5961160

object_name: biliary tract cancer


subject: UMLS:C5961160

object_name: non-small cell lung carcinoma


subject: UMLS:C5961160

object_name: gastroesophageal cancer


subject: UMLS:C5961160

object_name: adult hepatocellular carcinoma


subject: UMLS:C5961160

object_name: liver cancer


subject: UMLS:C5961160

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C5961160

object_name: liver carcinoma


subject: UMLS:C5961160

object_name: carcinoma of esophagus


subject: UMLS:C5961160

object_name: esophageal cancer


subject: UMLS:C5961160

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5961160

object_name: neoplasm of esophagus


subject: UMLS:C5961160

object_name: pancreatic neoplasm


subject: UMLS:C5961160

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5961160

object_name: malignant pancreatic neoplasm


subject: UMLS:C5961160

object_name: prostate carcinoma


subject: UMLS:C5961160

object_name: prostate cancer


subject: UMLS:C5961160

object_name: Stomach cancer


subject: UMLS:C5961160

object_name: gastric cancer


subject: UMLS:C5961160

object_name: thyroid tumor


subject: UMLS:C5961160

object_name: thyroid gland carcinoma


subject: UMLS:C5961160

object_name: thyroid cancer


subject: UMLS:C5961160

object_name: rectal carcinoma


subject: UMLS:C5961160

object_name: rectal cancer


subject: UMLS:C5961160

object_name: Childhood Rectal Carcinoma


subject: UMLS:C5961160

object_name: Childhood Breast Carcinoma


subject: UMLS:C5961160

object_name: breast carcinoma


subject: UMLS:C5961160

object_name: breast cancer


subject: UMLS:C5961160

object_name: colon carcinoma


subject: UMLS:C5961160

object_name: colorectal cancer


subject: UMLS:C5961160

object_name: colon cancer


subject: UMLS:C5961160

object_name: renal carcinoma


subject: UMLS:C5961160

object_name: kidney cancer


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:40968

object_name: metabolic syndrome X


subject: CHEBI:4875

subject_name: Etanercept

object_name: psoriasis-related juvenile idiopathic arthritis


subject: CHEBI:4875

object_name: Polyarthritis, Juvenile, Rheumatoid Factor Negative


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: hemophilia A


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:32599

object_name: Shivering


subject: CHEBI:6754

subject_name: Meperidine


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: thrombocytopenia


subject: UNII:3A189DH42V

object_name: leukopenia


subject: UNII:3A189DH42V

object_name: neutropenia


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: pancytopenia


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C1455737

subject_name: Horse antigen


subject: UMLS:C1455737


subject: UMLS:C1455737


subject: UMLS:C1455737


subject: UMLS:C5551259

subject_name: HORSE


subject: UMLS:C5551259


subject: UMLS:C5551259


subject: UMLS:C5551259


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: UNII:CZO834LXQM

object_name: atrial fibrillation


subject: UNII:CZO834LXQM

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:CZO834LXQM

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:15605092


subject: PUBCHEM.COMPOUND:15605092


subject: PUBCHEM.COMPOUND:15605092


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Cancer of Neck


subject: PUBCHEM.COMPOUND:2767

object_name: Cancer of Head


subject: PUBCHEM.COMPOUND:2767

object_name: upper aerodigestive tract neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Head Neoplasms


subject: PUBCHEM.COMPOUND:2767

object_name: Neck Neoplasms


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UMLS:C3658959

object_name: COPD, severe early onset


subject: UMLS:C3658959

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4053636

subject_name: EGFR Antagonist Hemay022

object_name: Food-Drug Interactions


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Cirrhosis


subject: CHEBI:119915

object_name: liver cirrhosis


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: hepatitis C


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: lung cancer


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: lung neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: lung carcinoma


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UMLS:C4744543


subject: CHEBI:63617

subject_name: Pergolide

object_name: substance-related disorder


subject: CHEBI:63617

object_name: cocaine abuse


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: triple-negative breast carcinoma


subject: CHEBI:135918

object_name: Triple-Negative Breast Cancer Finding


subject: DRUGBANK:DB19449

object_name: plasma cell myeloma


subject: UMLS:C4722540

object_name: metastatic melanoma


subject: UMLS:C4722540

object_name: Childhood Solid Neoplasm


subject: UMLS:C4722540

object_name: Adult Solid Neoplasm


subject: UMLS:C4722540

object_name: Solid Neoplasm


subject: UMLS:C4722540

object_name: melanoma


subject: UMLS:C4722540

object_name: childhood neoplasm


subject: UMLS:C4722540

object_name: neoplastic syndrome


subject: UMLS:C4722540

object_name: cancer or benign tumor


subject: UMLS:C4722540

object_name: neoplasm


subject: CHEBI:167672

subject_name: Tovorafenib


subject: CHEBI:167672


subject: CHEBI:167672


subject: CHEBI:167672


subject: CHEBI:167672


subject: CHEBI:167672


subject: CHEBI:167672


subject: CHEBI:167672


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: Chronic uremia


subject: UNII:IY90U61Z3S

object_name: chronic kidney disease


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: UNII:0DW7MIH1VX


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:48720


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:6456

object_name: Dysmenorrhea


subject: CHEBI:125427

object_name: hypertension


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17026

subject_name: Progesterone

object_name: premature birth (history)


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3714501

object_name: obesity


subject: UMLS:C3714501

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:2269

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:2269

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:2269

object_name: glucose metabolism disease


subject: PUBCHEM.COMPOUND:2269

object_name: endocrine system disorder


subject: PUBCHEM.COMPOUND:2269

object_name: Inflammation


subject: PUBCHEM.COMPOUND:2269

object_name: metabolic disease


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:232799

subject_name: insulin lispro


subject: CHEBI:232799


subject: CHEBI:232799


subject: CHEBI:232799


subject: CHEBI:232799


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:8499

subject_name: Propranolol

object_name: plasma cell myeloma


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: colorectal neoplasm


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: metastatic colorectal cancer


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Familial hypercholesterolemia - heterozygous


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor


subject: CHEBI:50949

object_name: Depressed mood


subject: CHEBI:50949

object_name: Cancer patients and suicide and depression


subject: CHEBI:50949

object_name: Depressed - symptom


subject: CHEBI:50949

object_name: Depression, CTCAE


subject: CHEBI:50949

object_name: Poisoning by, adverse effect of and underdosing of other antidepressants


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Non-small cell lung cancer with mutation in epidermal growth factor receptor


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: pulmonary eosinophilia


subject: UMLS:C4722640

subject_name: GS/pan-Notch Inhibitor AL101

object_name: triple-negative breast carcinoma


subject: UMLS:C4722640

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:50733

subject_name: nutraceutical

object_name: type 1 diabetes mellitus 1


subject: CHEBI:50733

object_name: type 1 diabetes mellitus


subject: MESH:D056692

subject_name: Prebiotics


subject: MESH:D056692


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3696061

subject_name: saffron extract


subject: UMLS:C3696061


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Inflammation


subject: CHEBI:135207

object_name: lung cancer


subject: CHEBI:135207

object_name: lung neoplasm


subject: CHEBI:135207

object_name: lung carcinoma


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:4055

subject_name: Cytisine


subject: CHEBI:4055


subject: CHEBI:4055


subject: CHEBI:4055


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: glioblastoma


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Vaso-Occlusive Crisis


subject: UMLS:C2346514

object_name: sickle cell disease


subject: UMLS:C2346514

object_name: pain agnosia


subject: UMLS:C2346514

object_name: Pain insensitivity


subject: UMLS:C2346514

object_name: Vaso-occlusive pain episode in sickle cell disease


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: ALK Fusion Protein Expression


subject: UMLS:C0599934

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: urinary tract infection


subject: CHEBI:6888

object_name: bacterial urinary tract infection


subject: CHEBI:6888

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: triple-negative breast carcinoma


subject: CHEBI:6801

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:45783

subject_name: Imatinib

object_name: Adult Meningioma


subject: CHEBI:45783

object_name: Adult Grade II Meningioma


subject: CHEBI:45783

object_name: Adult Grade I Meningioma


subject: CHEBI:45783

object_name: Adult Grade III Meningioma


subject: CHEBI:45783

object_name: adult meningeal hemangiopericytoma


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: Heartburn


subject: CHEBI:63660

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:63618

subject_name: Pravastatin


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:91512

object_name: leukemia


subject: CHEBI:91512

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:3540

subject_name: cephalotaxine


subject: CHEBI:3540


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: CHEBI:681850

subject_name: Conivaptan

object_name: severe traumatic brain injury


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Acute low back pain


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: silent pituitary adenoma


subject: CHEBI:4466

object_name: non-functioning pituitary adenoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:8024

subject_name: Perindopril

object_name: Hematoma, Subdural, Chronic


subject: CHEBI:197638

subject_name: Carzinophilin

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL4298207

subject_name: ZILUCOPLAN

object_name: immune-mediated necrotizing myopathy


subject: CHEBI:229659

subject_name: Zilucoplan


subject: CHEBI:10127

subject_name: Zonisamide

object_name: epilepsy


subject: DRUGBANK:DB16486

object_name: atopic eczema


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: kidney failure


subject: UMLS:C2352429

subject_name: imvamune

object_name: smallpox